Brief: Tela Bio Q2 Revenue Rose 38 Percent To $10.4 Million
10/08/2022 21:58
TELA Bio Inc TELA.O :
* TELA BIO REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
* SEES FY REVENUE $42 MILLION TO $45 MILLION
* Q2 REVENUE ROSE 38 PERCENT TO $10.4 MILLION
* CASH AND CASH EQUIVALENTS ON JUNE 30, 2022, TOTALED $27.7
MILLION
* QTRLY NET LOSS PER COMMON SHARE, BASIC AND DILUTED $0.88
Source text for Eikon: ID:nGNX29hqxc
Further company coverage: TELA.O
Recent news on TELA Bio
See all newsTELA Bio Q1 revenue growth beats estimates, loss widens
Brief: TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million
Brief: Tela Bio Announces Inducement Grants Under Nasdaq Listing Rule
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly
Brief: TELA Bio Announces Pricing Of $13.0 Million Underwritten Registered Direct Offering Of Common Stock And Pre-Funded Warrants